Machine Learning for the Prediction of Lymph Nodes Micrometastasis in Patients with Non-Small Cell Lung Cancer: A Comparative Analysis of Two Practical Prediction Models for Gross Target Volume Delineation

References

• Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1–24. doi:10.1016/j.ccm.2019.10.00132008623
   PubMed Web of Science ®Google Scholar
• Cortes J, Perez-García JM, Llombart-Cussac A, et al. Enhancing global access to cancer medicines. CA Cancer J Clin. 2020;70(2):105–124. doi:10.3322/caac.2159732068901
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454. doi:10.1038/nature2518329364287
   PubMed Web of Science ®Google Scholar
• Shirai K, Kubota Y, Ohno T, et al. Carbon-ion radiotherapy for isolated lymph node metastasis after surgery or radiotherapy for lung cancer. Front Oncol. 2019;9:731. doi:10.3389/fonc.2019.0073131448233
   PubMed Web of Science ®Google Scholar
• De Leyn P, Dooms C, Kuzdzal J, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(5):787–798. doi:10.1093/ejcts/ezu02824578407
   PubMed Web of Science ®Google Scholar
• Brooks ED, Verma V, Senan S, et al. Salvage therapy for locoregional recurrence after stereotactic ablative radiotherapy for early-stage NSCLC. J Thorac Oncol. 2020;15(2):176–189. doi:10.1016/j.jtho.2019.10.01631712134
   PubMed Web of Science ®Google Scholar
• Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. doi:10.3322/caac.2138828094848
   PubMed Web of Science ®Google Scholar
• Lee NK, Moon SH, Kim TH, et al. Prognostic value of gross tumor volume for definitive radiation therapy in patients with locoregionally recurrent non-small-cell lung cancer after surgical resection. Clin Lung Cancer. 2013;14(4):399–406. doi:10.1016/j.cllc.2012.11.00223276823
   PubMed Web of Science ®Google Scholar
• Dreiseitl S, Ohno-Machado L. Logistic regression and artificial neural network classification models: a methodology review. J Biomed Inform. 2002;35(5–6):352–359. doi:10.1016/S1532-0464(03)00034-012968784
   PubMed Web of Science ®Google Scholar
• Wu S, Roberts K, Datta S, et al. Deep learning in clinical natural language processing: a methodical review. J Am Med Inform Assoc. 2020;27(3):457–470. doi:10.1093/jamia/ocz20031794016
   PubMed Web of Science ®Google Scholar
• Song L, Langfelder P, Horvath S. Random generalized linear model: a highly accurate and interpretable ensemble predictor. BMC Bioinform. 2013;14:5. doi:10.1186/1471-2105-14-5
   PubMed Web of Science ®Google Scholar
• Graham AN, Chan KJ, Pastorino U, Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 1999;117(2):246–251. doi:10.1016/S0022-5223(99)70419-89918964
   PubMed Web of Science ®Google Scholar
• Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111(6):1718–1723. doi:10.1378/chest.111.6.17189187199
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–1474. doi:10.1245/s10434-010-0985-420180029
   PubMed Web of Science ®Google Scholar
• Nambu A, Kato S, Motosugi U, et al. Thin-section CT of the mediastinum in preoperative N-staging of non-small cell lung cancer: comparison with FDG PET. Eur J Radiol. 2010;73(3):510–517. doi:10.1016/j.ejrad.2009.01.02119246170
   PubMed Web of Science ®Google Scholar
• Feng SH, Yang ST. The new 8th TNM staging system of lung cancer and its potential imaging interpretation pitfalls and limitations with CT image demonstrations. Diagn Interv Radiol. 2019;25(4):270–279. doi:10.5152/dir.2019.1845831295144
   PubMed Web of Science ®Google Scholar
• Armstrong RA. When to use the Bonferroni correction. Ophthalmic Physiol Opt. 2014;34(5):502–508. doi:10.1111/opo.1213124697967
   PubMed Web of Science ®Google Scholar
• Strobl C, Boulesteix AL, Zeileis A, Hothorn T. Bias in random forest variable importance measures: illustrations, sources, and a solution. BMC Bioinform. 2007;8:25. doi:10.1186/1471-2105-8-25
   PubMed Web of Science ®Google Scholar
• Scott M, Flaherty D, Currall J. Statistics: general linear models (a flexible approach). J Small Anim Pract. 2014;55(10):527–530. doi:10.1111/jsap.1226025134691
   PubMed Web of Science ®Google Scholar
• Kristensen E, Guerin-Dugué A, Rivet B. Regularization and a general linear model for event-related potential estimation. Behav Res Methods. 2017;49(6):2255–2274. doi:10.3758/s13428-017-0856-z28275950
   PubMed Web of Science ®Google Scholar
• Qu Y, Luo J. Estimation of group means when adjusting for covariates in generalized linear models. Pharm Stat. 2015;14(1):56–62. doi:10.1002/pst.165825406099
   PubMed Web of Science ®Google Scholar
• Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4(5):568–577. doi:10.1097/JTO.0b013e3181a0d82e19357537
   PubMed Web of Science ®Google Scholar
• Nagata Y, Hiraoka M, Shibata T, et al. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan clinical oncology group study JCOG0403. Int J Radiat Oncol Biol Phys. 2015;93(5):989–996. doi:10.1016/j.ijrobp.2015.07.227826581137
   PubMed Web of Science ®Google Scholar
• Gorai A, Sakao Y, Kuroda H, et al. The clinicopathological features associated with skip N2 metastases in patients with clinical stage IA non-small-cell lung cancer. Eur J Cardiothorac Surg. 2015;47(4):653–658. doi:10.1093/ejcts/ezu24424957260
   PubMed Web of Science ®Google Scholar
• Kelsey CR, Marks LB, Hollis D, et al. Local recurrence after surgery for early-stage lung cancer: an 11-year experience with 975 patients. Cancer. 2009;115(22):5218–5227. doi:10.1002/cncr.2462519672942
   PubMed Web of Science ®Google Scholar
• Yu Y, Zhao Q, He XP, Wang Z, Liu XY, Zhang ZP. Signal transducer and activator of transcription 3 overexpression promotes lymph node micrometastasis in early-stage non-small cell lung cancer. Thorac Cancer. 2018;9(5):516–522. doi:10.1111/1759-7714.1259829575778
   PubMed Web of Science ®Google Scholar
• Vorwerk H, Beckmann G, Bremer M, et al. The delineation of target volumes for radiotherapy of lung cancer patients. Radiother Oncol. 2009;91(3):455–460. doi:10.1016/j.radonc.2009.03.01419339069
   PubMed Web of Science ®Google Scholar
• Herth FJ, Eberhardt R, Krasnik M, Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest. 2008;133(4):887–891. doi:10.1378/chest.07-253518263680
   PubMed Web of Science ®Google Scholar
• Haruki T, Wakahara M, Matsuoka Y, et al. Clinicopathological characteristics of lung adenocarcinoma with unexpected lymph node metastasis. Ann Thorac Cardiovasc Surg. 2017;23(4):181–187. doi:10.5761/atcs.oa.16-0030928539542
   PubMed Web of Science ®Google Scholar
• Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer. J Thorac Cardiovasc Surg. 2004;127(4):1087–1092. doi:10.1016/j.jtcvs.2003.08.01015052206
   PubMed Web of Science ®Google Scholar
• Kaseda K, Asakura K, Kazama A, Ozawa Y. Risk factors for predicting occult lymph node metastasis in patients with clinical stage I non-small cell lung cancer staged by integrated fluorodeoxyglucose positron emission tomography/computed tomography. World J Surg. 2016;40(12):2976–2983. doi:10.1007/s00268-016-3652-527456499
   PubMed Web of Science ®Google Scholar
• Murgu SD. Diagnosing and staging lung cancer involving the mediastinum. Chest. 2015;147(5):1401–1412. doi:10.1378/chest.14-135525940251
   PubMed Web of Science ®Google Scholar
• van den Brekel MW, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology. 1990;177(2):379–384. doi:10.1148/radiology.177.2.22177722217772
   PubMed Web of Science ®Google Scholar
• de Vries FE, da Costa DW, van der Mooren K, van Dorp TA, Vrouenraets BC. The value of preoperative computed tomography scanning for the assessment of lymph node status in patients with colon cancer. Eur J Surg Oncol. 2014;40(12):1777–1781. doi:10.1016/j.ejso.2014.08.48325260599
   PubMed Web of Science ®Google Scholar
• Chen K, Yang F, Jiang G, Li J, Wang J. Development and validation of a clinical prediction model for N2 lymph node metastasis in non-small cell lung cancer. Ann Thorac Surg. 2013;96(5):1761–1768. doi:10.1016/j.athoracsur.2013.06.03823998401
   PubMed Web of Science ®Google Scholar
• Billé A, Pelosi E, Skanjeti A, et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg. 2009;36(3):440–445. doi:10.1016/j.ejcts.2009.04.00319464906
   PubMed Web of Science ®Google Scholar
• Zhao F, Zhen FX, Zhou Y, et al. Clinicopathologic predictors of metastasis of different regional lymph nodes in patients intraoperatively diagnosed with stage-I non-small cell lung cancer. BMC Cancer. 2019;19(1):444. doi:10.1186/s12885-019-5632-231088404
   PubMed Web of Science ®Google Scholar
• Yanagawa N, Shiono S, Abiko M, Ogata SY, Sato T, Tamura G. The correlation of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification with prognosis and EGFR mutation in lung adenocarcinoma. Ann Thorac Surg. 2014;98(2):453–458. doi:10.1016/j.athoracsur.2014.04.10824961844
   PubMed Web of Science ®Google Scholar
• Ito M, Miyata Y, Kushitani K, et al. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications. Lung Cancer. 2014;85(2):270–275. doi:10.1016/j.lungcan.2014.05.01424976332
   PubMed Web of Science ®Google Scholar
• Moon Y, Kim KS, Sung SW, et al. Correlation of histological components with tumor invasion in pulmonary adenocarcinoma. World J Surg Onc. 2014;12:388. doi:10.1186/1477-7819-12-388
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Wood DE, Akerley W, et al. Non-small cell lung cancer, version 6.2015. J Natl Compr Canc Netw. 2015;13(5):515–524. doi:10.6004/jnccn.2015.007125964637
   PubMed Web of Science ®Google Scholar
• Dong M, Liu J, Sun X, Xing L. Prognostic significance of SUV(max) on pretreatment (18) F-FDG PET/CT in early-stage non-small cell lung cancer treated with stereotactic body radiotherapy: a meta-analysis. J Med Imaging Radiat Oncol. 2017;61(5):652–659. doi:10.1111/1754-9485.1259928266166
   PubMed Web of Science ®Google Scholar